VIVEbiotech celebrates International Biotechnology Day by highlighting its role in advanced therapies
With a decade of experience in lentiviral vectors, VIVEbiotech reaffirms its commitment to driving global biotech innovation.
On June 16, the world celebrated International Biotechnology Day, a moment to recognize how biotechnology continues to transform healthcare. At VIVEbiotech, we proudly contribute to this progress through our specialization in the development and manufacturing of lentiviral vectors.
With over 10 years of experience, we have produced more than 50 GMP batches—half of them in just the last three years—demonstrating our growing impact. Our projects span the US, Europe, Asia, and Australia, and comply with both FDA and EMA standards.
We also bring robust expertise in the manufacturing of lentiviral vectors for in vivo administration, positioning us as a trusted partner for gene and cell therapy developers worldwide.